These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4557535)

  • 1. The effect of colestipol or cholestyramine on serum cholesterol and triglycerides in a long-term controlled study.
    Ryan JR; Jain A
    J Clin Pharmacol New Drugs; 1972 Jul; 12(7):268-73. PubMed ID: 4557535
    [No Abstract]   [Full Text] [Related]  

  • 2. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.
    Glueck CJ; Ford S; Scheel D; Steiner P
    JAMA; 1972 Nov; 222(6):676-81. PubMed ID: 4562098
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia.
    Miller NE; Clifton-Bligh P; Nestel PJ; Whyte HM
    Med J Aust; 1973 Jun; 1(25):1223-7. PubMed ID: 4579666
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term cholesterol-lowering effect of colestipol resin in humans.
    Gross L; Figueredo R
    J Am Geriatr Soc; 1973 Dec; 21(12):552-6. PubMed ID: 4584170
    [No Abstract]   [Full Text] [Related]  

  • 5. Colestipol and clofibrate in hypercholesterolemia.
    Dujovne CA; Hurwitz A; Kauffman RE; Azarnoff DL
    Clin Pharmacol Ther; 1974 Aug; 16(2):291-6. PubMed ID: 4604239
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased plasma cholesterol esterifying activity during Colestipol resin therapy in man.
    Clifton-Bligh P; Miller NE; Nestel PJ
    Metabolism; 1974 May; 23(5):437-44. PubMed ID: 4825300
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in plasma lipoprotein lipids in hypercholesterolaemic patients treated with the bile acid-sequestering resin, colestipol.
    Clifton-Bligh P; Miller NE; Nestel PJ
    Clin Sci Mol Med; 1974 Dec; 47(6):547-57. PubMed ID: 4375013
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man.
    Miller NE; Clifton-Bligh P; Nestel PJ
    J Lab Clin Med; 1973 Dec; 82(6):876-90. PubMed ID: 4758739
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term treatment of hypercholesterolemia with colestipol hydrochloride.
    Ryan JR; Jain AK; McMahon FG
    Clin Pharmacol Ther; 1975 Jan; 17(1):83-7. PubMed ID: 1091391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of hyperlipoproteinemia to colestipol.
    Sachs BA; Wolfman L
    N Y State J Med; 1973 May; 73(9):1068-70. PubMed ID: 4512165
    [No Abstract]   [Full Text] [Related]  

  • 11. Colestipol therapy of hyperlipidemia in man.
    Sachs BA; Wolfman L
    Proc Soc Exp Biol Med; 1974 Dec; 147(3):694-7. PubMed ID: 4445156
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypocholesterolemic activity of colestipol in diabetes.
    Bandisode MS; Boshell BR
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):276-84. PubMed ID: 809240
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of hypercholesterolemia with Secholex. A long-term clinical trial and comparison with cholestyramine.
    Nikkila EA; Miettinen TA; Lanner A
    Atherosclerosis; 1976 Sep; 24(3):407-19. PubMed ID: 971343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of colestipol, a new bile acid sequestrant, on the absorption of phenprocoumon in man.
    Harvengt C; Desager JP
    Eur J Clin Pharmacol; 1973 Jun; 6(1):19-21. PubMed ID: 4764368
    [No Abstract]   [Full Text] [Related]  

  • 15. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined use of clofibrate and anion exchange in the treatment of hypercholesterolemia.
    Howard AN; Hyams DE; Evans C
    Adv Exp Med Biol; 1972; 26(0):179-87. PubMed ID: 4679724
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
    Crouse JR
    Am J Med; 1987 Aug; 83(2):243-8. PubMed ID: 3618626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
    Day CE
    Artery; 1990; 17(5):281-8. PubMed ID: 2396902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
    Mordasini R; Twelsick F; Oster P; Schellenberg B; Raetzer H; Heuck CC; Schlierf G
    Monatsschr Kinderheilkd (1902); 1978 Jul; 126(7):436-40. PubMed ID: 672910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertriglyceridemia: a relative contraindication to the use of bile acid-binding resins?
    Denke MA; Grundy SM
    Hepatology; 1988; 8(4):974-5. PubMed ID: 3391527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.